Emerging Approaches to Assess Pro-Arrhythmia Risk in Drug Development: Moving Beyond hERG and QTc

Date & Time

Mar 6th at 1:00 PM until 2:30 PM



Rating ( votes)

The goal of this workshop is to highlight the impact of various quantitative mechanistic approaches for the assessment of pro-arrhythmia risk of drugs in development, with particular emphasis on the integration of preclinical data to provide optimal models for decision making. An additional goal would be to understand the value of these approaches in supplanting the current TQT studies. The views of academia, industry, and regulatory agency, will be represented in the symposium to demonstrate how these methods can be applied for successful development of therapeutics.